food and drug administration news

FDA issues recall notices for two brands of pet food

Salmonella and Listeria Found in 2 Pet Food Brands: Everything to Know

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

YAHOO!News · 21h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

AOL · 1d

These 2 brands of pet food may be contaminated with salmonella and listeria, FDA says

The U.S. FDA issued warnings for ANSWERS Pet Food and Darwin's Natural Pet Products as they contain Salmonella and Listeria. Biggest risk is passing it on to humans.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 22h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 21h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 22h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

FDA Approves 1st New Schizophrenia Drug in Decades

Time on MSN · 3h

FDA Approves the First New Schizophrenia Drug in Decades

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.

ABC News on MSN · 18h

FDA approves 1st new drug to treat schizophrenia in more than 30 years

This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a new alternative to the antipsychotic medications peo

Gizmodo · 1h

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.

We need a Food and Drug Administration for AI

We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?

McKnight's Long-Term Care News19h

Journalists question safety and effectiveness of new Alzheimer’s drug

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

What We Know (and Don’t Know) About ‘Forever Chemicals’ in Food

A growing body of research shows that exposure can increase the risk of prostate, kidney and testicular cancers. The ...

11h

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

Investopedia17d

Food and Drug Administration (FDA): What It Is and Does

Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...

Medical Xpress7d

News on drug administration

Consumers should be aware that some chocolate labeled as "dairy-free" actually contains milk, the U.S. Food and Drug Administration warns. This inaccurate labeling could put people with milk ...

Nasdaq1mon

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

to U.S. Food and Drug Administration (FDA) for LNZ100 (an aceclidine-based ophthalmic solution) for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally ...

Sanofi blockbuster drug wins clearance in US for lung disease

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results